Canine CD8 T cells showing NK cytotoxic activity express mRNAs for NK cell-associated surface molecules

Veterinary Immunology and Immunopathology

Volumn 133, Issue 2-4, 2010, Pages 144-153

  Lin, Yi Chun ^a   Huang, Yi Chun ^a   Wang, Yu Shan ^a,b   Juang, Rong Huay ^a   Liao, Kuang Wen ^c   Chu, Rea Min ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Canine; CD8+; Cytotoxicity; NK cell; NKp30

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; INTERLEUKIN 2; LYMPHOCYTE SURFACE MARKER; LYMPHOKINE; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CELL LINE; CELL SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; GENE EXPRESSION; LARGE GRANULAR LYMPHOCYTE; LYMPHOCYTE STRUCTURE; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; DOGS; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, NATURAL KILLER CELL; RNA, MESSENGER;

CANIS FAMILIARIS; MAMMALIA;

EID: 72449144569     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.07.013     Document Type: Article

References (37)

1. Abedin S., Michel J.J., Lemster B., and Vallejo A.N. Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Exp. Gerontol. 40 (2005) 537-548
2. Backstrom E., Kristensson K., and Ljunggren H.G. Activation of natural killer cells: underlying molecular mechanisms revealed. Scand. J. Immunol. 60 (2004) 14-22
3. Biassoni R., Cantoni C., Pende D., Sivori S., Parolini S., Vitale M., Bottino C., and Moretta A. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181 (2001) 203-214
4. Bonkobara M., Sato T., Takahashi N., Kasahara Y., Yagihara H., Tamura K., Isotani M., Azakami D., Ono K., and Washizu T. Characterization of cDNA and the genomic sequence encoding canine neural-cell adhesion molecule, CD56/N-CAM. Vet. Immunol. Immunopathol. 107 (2005) 171-176
5. Boysen P., Olsen I., Berg I., Kulberg S., Johansen G.M., and Storset A.K. Bovine CD2-/NKp46+ cells are fully functional natural killer cells with a high activation status. BMC Immunol. 7 (2006) 10
6. Cantoni C., Bottino C., Vitale M., Pessino A., Augugliaro R., Malaspina A., Parolini S., Moretta L., Moretta A., and Biassoni R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 189 (1999) 787-796
7. Cerwenka A., and Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1 (2001) 41-49
8. De Maria A., Biassoni R., Fogli M., Rizzi M., Cantoni C., Costa P., Conte R., Mavilio D., Ensoli B., Cafaro A., Moretta A., and Moretta L. Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells. Eur. J. Immunol. 31 (2001) 3546-3556
9. Gagnier L., Wilhelm B.T., and Mager D.L. Ly49 genes in non-rodent mammals. Immunogenetics 55 (2003) 109-115
10. Guenther W., Schumm M., Buettner M., Voss C., Kremmer E., Thierfelder S., Wilmanns W., and Kolb H.J. NK activity of canine blood and marrow cells. Tissue Antigens 43 (1994) 198-201
11. Helfand S.C., Modiano J.F., Moore P.F., Soergel S.A., MacWilliams P.S., Dubielzig R.D., Hank J.A., Gelfand E.W., and Sondel P.M. Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphoma. Blood 86 (1995) 636-645
12. Hollyoake M., Campbell R.D., and Aguado B. NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli. Mol. Biol. Evol. 22 (2005) 1661-1672
13. Hsiao Y.W., Liao K.W., Hung S.W., and Chu R.M. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells. Vet. Immunol. Immunopathol. 87 (2002) 19-27
14. Hsiao Y.W., Liao K.W., Hung S.W., and Chu R.M. Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity. J. Immunol. 172 (2004) 1508-1514
15. Hsieh C.L., Ogura Y., Obara H., Ali U.A., Rodriguez G.M., Nepomuceno R.R., Martinez O.M., and Krams S.M. Identification, cloning, and characterization of a novel rat natural killer receptor, RNKP30: a molecule expressed in liver allografts. Transplantation 77 (2004) 121-128
16. Hsieh C.L., Nagasaki K., Martinez O.M., and Krams S.M. NKp30 is a functional activation receptor on a subset of rat natural killer cells. Eur. J. Immunol. (2006)
17. Huang Y.C., Hung S.W., Jan T.R., Liao K.W., Cheng C.H., Wang Y.S., and Chu R.M. CD5-low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells. J. Leukoc. Biol. 84 (2008) 1501-1510
18. Ishiyama T., Watanabe K., Fukuchi K., Yajima K., Koike M., Tomoyasu S., and Tsuruoka N. The presence of CD5LOW + NK cells in normal controls and patients with pulmonary tuberculosis. Immunol. Lett. 37 (1993) 139-144
19. Jardine J.H., Jackson H.J., Lotzova E., Savary C.A., and Small S.M. Tumoricidal effect of interleukin-2-activated killer cells in canines. Vet. Immunol. Immunopathol. 21 (1989) 153-160
20. Kiessling R., Petranyi G., Karre K., Jondal M., Tracey D., and Wigzell H. Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J. Exp. Med. 143 (1976) 772-780
21. Knapp D.W., Turek J.J., DeNicola D.B., Chan T.C., Carter W.O., Snyder P.W., and Robinson J.P. Ultrastructure and cytochemical staining characteristics of canine natural killer cells. Anat. Rec. 243 (1995) 509-515
22. Lanier L.L., Corliss B., Wu J., and Phillips J.H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8 (1998) 693-701
23. Ljunggren H.G., and Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11 (1990) 237-244
24. Loughran Jr. T.P., Deeg H.J., and Storb R. Morphologic and phenotypic analysis of canine natural killer cells: evidence for T-cell lineage. Cell. Immunol. 95 (1985) 207-217
25. Loughran Jr. T.P., Deeg H.J., and Storb R. Inhibition of canine NK activity by anti-CD18 monoclonal antibody, UV irradiation and cyclosporine. Exp. Hematol. 21 (1993) 411-413
26. McQueen K.L., and Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14 (2002) 615-621
27. Moebius U., Kober G., Griscelli A.L., Hercend T., and Meuer S.C. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur. J. Immunol. 21 (1991) 1793-1800
28. Moretta L., Biassoni R., Bottino C., Cantoni C., Pende D., Mingari M.C., and Moretta A. Human NK cells and their receptors. Microbes Infect. 4 (2002) 1539-1544
29. Odeberg J., Browne H., Metkar S., Froelich C.J., Branden L., Cosman D., and Soderberg-Naucler C. The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J. Virol. 77 (2003) 4539-4545
30. Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., Marcenaro E., Accame L., Malaspina A., Biassoni R., Bottino C., Moretta L., and Moretta A. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190 (1999) 1505-1516
31. Sawicki M.W., Dimasi N., Natarajan K., Wang J., Margulies D.H., and Mariuzza R.A. Structural basis of MHC class I recognition by natural killer cell receptors. Immunol. Rev. 181 (2001) 52-65
32. Storset A.K., Kulberg S., Berg I., Boysen P., Hope J.C., and Dissen E. NKp46 defines a subset of bovine leukocytes with natural killer cell characteristics. Eur. J. Immunol. 34 (2004) 669-676
33. Timonen T., Ortaldo J.R., and Herberman R.B. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 153 (1981) 569-582
34. Torres-Nagel N., Kraus E., Brown M.H., Tiefenthaler G., Mitnacht R., Williams A.F., and Hunig T. Differential thymus dependence of rat CD8 isoform expression. Eur. J. Immunol. 22 (1992) 2841-2848
35. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., and Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187 (1998) 2065-2072
36. Wang Y.S., Chi K.H., and Chu R.M. Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation. Vet. Immunol. Immunopathol. 118 (2007) 186-198
37. Yang H., and Parkhouse R.M. Differential expression of CD8 epitopes amongst porcine CD8-positive functional lymphocyte subsets. Immunology 92 (1997) 45-52